Following the successful filing of Intellectual Property (IP) for their applied platform technology targeting the endocannabinoid system (ECS), Tetra Pharm Technologies, is moving forward with its compound for appetite suppression, TPT0701....
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its new analytical platform, LabZient™. The standardized and automated platform streamlines the assessment and validation of large...
Rehabtronics, a leading innovator in neurostimulation technologies, is pleased to announce that it has been selected by the Praxis Spinal Cord Institute to conduct a usability and validation study for its groundbreaking pressure injury early...
Evogene Ltd. a leading computational biology company targeting to revolutionize life-science product development across multiple market segments, and Verb Biotics LLC. A microbiome health ingredient company whose mission is to improve human...
Viscient Biosciences ("Viscient") announced that its scientists, along with collaborators from University of California, San Diego, Sanford-Burnham-Prebys medical research institute, and Salk Institute, have published the first demonstration of a...
CVS Pharmacy®, the retail division of CVS Health® (NYSE: CVS), today announced the evolution of its loyalty program to include two membership tiers: ExtraCare® and ExtraCare Plus™. ExtraCare: The popular, no-fee loyalty program through which...
Octapharma USA has announced Balfaxar® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex®) is now available. The new non-activated four factor prothrombin complex concentrate (4F-PCC), approved by the U.S....
How Does It Work? — Explore Our Comprehensive Services and Their Benefits Pharmaceutical-Era.com is dedicated to providing top-tier press release distribution, publication services, and event promotion exclusively for the pharmaceutical industry....
Editorial Guidelines At Pharmaceutical-Era.com, we strive to maintain the highest standards of quality and integrity in our editorial content. Our guidelines are designed to ensure that all articles, press releases, and other submissions are...
Privacy Policy At Pharmaceutical-Era, we are committed to protecting your privacy. This Privacy Policy outlines how we collect, use, and disclose personal information when you use our website (www.pharmaceutical-era.com). Information We Collect:...
Your Premier Global Platform for Pharmaceutical Insights and Events Welcome to Pharmaceutical Era, your trusted partner in navigating the dynamic landscape of the worldwide pharmaceutical industry. Established in 2011 by HISS Media Pvt Ltd, an...
Frequently Asked Questions (FAQs) What are the genuine benefits of using Pharmaceutical-Era.com for press release distribution or promotion? Pharmaceutical-Era.com offers unparalleled visibility to your press releases within the pharmaceutical...
Terms Of Use — Terms & Conditions Welcome to Pharmaceutical-Era (referred to as "Pharmaceutical-Era," "we," "us," or "our"). By accessing or using our website (www.pharmaceutical-era.com), you agree to comply with and be bound by the following...
